Title
IMP3, a new biomarker to predict progression of cervical intraepithelial neoplasia into invasive cancer
UMMS Affiliation
Department of Cancer Biology; Department of Medicine, Division of Preventive and Behavioral Medicine; Department of Pathology
Publication Date
2011-11
Document Type
Article
Subjects
Adult; Carcinoma, Squamous Cell; Cell Movement; Cell Proliferation; Cervical Intraepithelial Neoplasia; Disease Progression; Disease-Free Survival; Female; HeLa Cells; Humans; Kaplan-Meier Estimate; Massachusetts; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; RNA Interference; RNA-Binding Proteins; Time Factors; Tumor Markers, Biological; Uterine Cervical Neoplasms; Young Adult
Disciplines
Cancer Biology | Neoplasms | Pathology
Abstract
The expression of IMP3, an oncofetal protein, has been strongly associated with aggressive cancers. In this study, we investigated whether IMP3 can serve as a biomarker to predict invasive squamous cell carcinoma (SCC) in patients with cervical intraepithelial neoplasia (CIN) II and III. A total of 1249 patients with no dysplasia, CINs, or invasive SCC were studied for IMP3 expression. The 710 patients with CIN II and III in their cervical biopsies were further evaluated for invasive cancer-free survival analysis. The role of IMP3 in the regulation of cell proliferation and migration of HeLa cervical cancer cells was examined by modification of IMP3 expression with small interference RNA. Compared with CIN I or cervical tissues without dysplasia, IMP3 expression was significantly increased not only in invasive SCC but also most importantly in a subset of CIN III cases with concurrent invasive SCC. Importantly, invasive cancer was found only in patients with IMP3-positive CIN II and III, whereas no invasive cancer was detected in patients with IMP3-negative CIN II and III in their follow-up resections (P
DOI of Published Version
10.1097/PAS.0b013e31823272d4
Source
Am J Surg Pathol. 2011 Nov;35(11):1638-45. Link to article on publisher's site
Journal/Book/Conference Title
The American journal of surgical pathology
Related Resources
PubMed ID
21997684
Repository Citation
Lu D, Yang X, Jiang NY, Woda BA, Liu Q, Dresser KA, Mercurio AM, Rock KL, Jiang Z. (2011). IMP3, a new biomarker to predict progression of cervical intraepithelial neoplasia into invasive cancer. Cancer Biology Publications. https://doi.org/10.1097/PAS.0b013e31823272d4. Retrieved from https://escholarship.umassmed.edu/cancerbiology_pp/213